News
Sodium polystyrene sulfonate (SPS) has been commonly prescribed to treat hyperkalemia since its approval in 1959. Now new evidence published online ahead of print in JAMA Internal Medicine links ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback